By University of Wisconsin School of Medicine and Public Health –
A first-of-its-kind clinical trial at the Program for Advanced Cell Therapy will examine a new method to manage kidney rejection following transplant.
The Program for Advanced Cell Therapy, or PACT, a collaboration between UW Health and the University of Wisconsin School of Medicine and Public Health, will test the use of a patient’s own mesenchymal stromal cells. In this approach, cells taken from the patient’s lip are used to treat a specific type of organ rejection called T-cell mediated rejection, also called acute cellular rejection.
